FUJIFILM Holdings (4901) · InitiativeAchieved
Development of a DDS manufacturing platform through a new plant dedicated to liposomal formulations
First written in FY2020-Q3. 1 of 2 entries say "Achieved", first in FY2020. Latest entry: FY2020.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Operation of a new plant dedicated to liposomal formulations and establishment of a DDS contract manufacturing platformA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2020AchievedAnnual report
「In addition, a new plant dedicated to liposomal formulations, a drug delivery system (DDS) technology that selectively delivers drugs to enhance their efficacy, began operations in February 2020, and contract development and manufacturing services were launched.」
The new plant dedicated to liposomal formulations began operations in February 2020, leading to the launch of contract development and manufacturing services. - FY2020-Q3First statedAnnual report
「In addition, a new plant dedicated to liposomal formulations, a drug delivery system technology that selectively delivers drugs to enhance their efficacy, was completed. Operations are scheduled to begin in February 2020.」
A new plant dedicated to liposomal formulations was completed, with operations scheduled to begin in February 2020. This is the first disclosure of an initiative to establish a manufacturing base for DDS technology that selectively delivers drugs.